{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-361079","form_type":"8-K","ticker":"APVO","cik":"0001671584","company_name":"Aptevo Therapeutics Inc.","filed_at":"2026-08-21T20:05:14+00:00","discovered_at":"2026-08-21T20:06:00.714602+00:00","generated_at":"2026-08-21T20:06:15.020736+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Aptevo annual meeting: both director nominees elected, all four proposals approved","bullets":["Zs. Harsanyi re-elected director: 216,997 for, 17,454 withheld; Barbara Lopez Kunz: 211,050 for, 23,401 withheld.","Ratification of Baker Tilly US LLP as 2026 auditor: 606,661 for, 28,847 against, 1,370 abstain.","Advisory vote on 2025 executive compensation approved: 165,615 for, 24,031 against, 44,805 abstain.","Fourth Amended and Restated 2018 Stock Incentive Plan approved: 166,484 for, 64,248 against, 3,719 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-361079","json":"https://secwatch.observer/filing/0001193125-26-361079.json","markdown":"https://secwatch.observer/filing/0001193125-26-361079.md","text":"https://secwatch.observer/filing/0001193125-26-361079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526361079/0001193125-26-361079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526361079/apvo-20260821.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-21T20:06:15.020736+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}